SOURCE: annual_report_text (1).txt
CHUNK: 227 of 1106
SIZE: 493 characters
PREVIOUS: chunk_0226_annual_report_text (1).txt
NEXT: chunk_0228_annual_report_text (1).txt
------------------------------
ions have highly developed sales and 
marketing networks and more importantly, extensive 
financial 
resources 
beyond 
comparison with those of IBA. Furthermore, there is always the possibility that new 
technology notably a revolutionary therapy in 
the treatment of cancer that would render a part 
of IBAs current product line obsolete could be 
developed. The development and marketing of technology 
resulting in novel therapies do nevertheless 
require a relatively long period of time.